TrialScientific reports2016

Serpin peptidase inhibitor (SERPINB5) haplotypes are associated with susceptibility to hepatocellular carcinoma.

Shun-Fa Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.